ArticleMolecular cancer2024

Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer.

Tianlei Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.